New iNTApharma system enables rapid, native‑state size and concentration measurements with single‑particle sensitivity for viral, vesicle, and nanoscale bioparticle workflows Bruker’s iNTApharma ...
Innovative timsTOF platform combined with extreme MALDI PharmaPulse speed and robustness for unbiased, deep HTS and uHTS (ultra-high-throughput screening) Trapped Ion Mobility Spectrometry (TIMS): ...
Discover much more about Bruker's Pharma offerings - here is a sneak preview for SLAS 2021.
The rapifleX MALDI PharmaPulse (MPP) accelerates label-free hit finding in drug discovery: rapifleX MPP combines the unambiguousness of mass spectrometry with the required speed to comb through large ...
Bruker announces a co-marketing agreement with Cellenion on the cellenONE single-cell isolation and nanoliter dispensing robotic platform. The partnership with Cellenion on label-free 4D single-cell ...
New iNTApharma system enables rapid, native‑state size and concentration measurements with single‑particle sensitivity for viral, vesicle, and nanoscale bioparticle workflows iNTApharma builds on ...
Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results